A cytokine screen further revealed that glioma stem cells released many molecules that enhanced MDSCs mediated immune suppression, including macrophage migration inhibitory factor (MIF), which acts to decrease immunological rejection by triggering and maintaining immune suppressive MDSCs in the GBM TME (138, 139). The gene discussed is MIF; the disease is central nervous system cancer.